Page 1 | Search Results | Hematology, ASH Education Program

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Chronic organ failure in adult sickle cell disease

Elliott Vichinsky

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 435–439.

https://doi.org/10.1182/asheducation-2017.1.435

Published: 2017

Journal Articles

Emerging ‘A’ therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine

Elliott Vichinsky

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 271–275.

https://doi.org/10.1182/asheducation.V2012.1.271.3798318

Published: 2012

Journal Articles

Pulmonary Hypertension, Tricuspid Regurgitant Velocity Screening, and the Nitric Oxide Pathway

Kathryn L. Hassell

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 419–426.

https://doi.org/10.1182/asheducation-2011.1.419

Published: 2011

Journal Articles

Novel therapies in sickle cell disease

Kenneth I. Ataga

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 54–61.

https://doi.org/10.1182/asheducation-2009.1.54

Published: 2009

Journal Articles

Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia

Claudia R. Morris

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 177–185.

https://doi.org/10.1182/asheducation-2008.1.177

Published: 2008

Journal Articles

Novel Small Molecule Therapeutics for Sickle Cell Disease: Nitric Oxide, Carbon Monoxide, Nitrite, and Apolipoprotein A-I

Gregory J. Kato

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 186–192.

https://doi.org/10.1182/asheducation-2008.1.186

Published: 2008

Journal Articles

Hemoglobin E Syndromes

Elliott Vichinsky

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 79–83.

https://doi.org/10.1182/asheducation-2007.1.79

Published: 2007

Journal Articles

Cardiopulmonary Complications of Sickle Cell Disease: Role of Nitric Oxide and Hemolytic Anemia

Mark T. Gladwin, Gregory J. Kato

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 51–57.

https://doi.org/10.1182/asheducation-2005.1.51

Published: 2005

NARROW

Chronic organ failure in adult sickle cell disease

Emerging ‘A’ therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine

Pulmonary Hypertension, Tricuspid Regurgitant Velocity Screening, and the Nitric Oxide Pathway

Novel therapies in sickle cell disease

Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia

Novel Small Molecule Therapeutics for Sickle Cell Disease: Nitric Oxide, Carbon Monoxide, Nitrite, and Apolipoprotein A-I

Hemoglobin E Syndromes

Cardiopulmonary Complications of Sickle Cell Disease: Role of Nitric Oxide and Hemolytic Anemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only